B. Braun Expands Clinical Nutrition Portfolio

B. Braun Expands Clinical Nutrition Portfolio

ID: 364133

Launches Nutrilipid(R) 20% -- An Intravenous Fat Emulsion


(firmenpresse) - BETHLEHEM, PA -- (Marketwired) -- 01/13/15 -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today the launch of Nutrilipid® 20% (I.V. fat emulsion) for parenteral nutrition therapy.

The launch of will help alleviate the short supply of lipid emulsion products the U.S. has seen over the past few years. It will be available in flexible containers that are not made with natural rubber latex, DEHP or PVC. B.Braun's clinical nutrition compounding offering now also includes Sterile Water for Injection USP in TITAN™ XL 2L and 3L containers, the only large-volume, flexible containers approved in the U.S. that are not made with natural rubber latex, DEHP or PVC.

"Through our state-of-the-art production facility, we are committed to providing quality clinical nutrition products so that patients have access to parenteral nutrition they often critically need," said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun.

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit .



Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Boston Eye Surgeons Reveal Top Symptoms and Treatments for Cataracts owing to a range of selections
Bereitgestellt von Benutzer: Marketwired
Datum: 13.01.2015 - 19:10 Uhr
Sprache: Deutsch
News-ID 364133
Anzahl Zeichen: 0

contact information:
Town:

BETHLEHEM, PA



Kategorie:

Health & Nutrition



Diese Pressemitteilung wurde bisher 221 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"B. Braun Expands Clinical Nutrition Portfolio"
steht unter der journalistisch-redaktionellen Verantwortung von

B. Braun Medical Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von B. Braun Medical Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z